MECP2 and Rett syndrome: As the restoration of MeCP2 protein levels is a favorable therapeutic avenue in the treatment of RTT, the induction of MeCP2 levels by metformin may be applicable for neurological diseases with MeCP2 loss-of-function mutations such as RTT, or decreased protein expression of MeCP2.